Concanavalin A targets phylogenetically conserved N-linked glycans on coronavirus spike proteins for broad-spectrum antiviral activity
Journal of Virology · 19.05.2026 · 100 (5)
DOI: 10.1128/jvi.01679-25 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Virology, erschienen am 19.05.2026. Verfasst von Dekuan Guo und 10 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Traditional Chinese Medicine Syndrome, Guangzhou University of Chinese Medicine, Guangzhou, China. Hauptthemen laut MEDLINE: Spike Glycoprotein, Coronavirus, Concanavalin A, Polysaccharides, Antiviral Agents. Die Arbeit nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The rapid evolution of SARS-CoV-2 variants, driven by antigenic drift in the spike glycoprotein, continues to undermine the efficacy of current vaccines and monoclonal antibody therapies. Targeting conserved features of the spike protein has been a major focus against coronavirus entry and the development of therapeutics. Here, we demonstrate that the plant lectin concanavalin A (ConA) broadly inhibits coronavirus entry through a conserved mechanism. With a combination of cell-cell fusion, pseudoviral entry, and authentic virus infection models, we show that ConA broadly inhibits coronavirus spike-mediated membrane fusion and viral entry. Biochemical analyses reveal that ConA targets two highly conserved N-glycosylation sites outside the receptor binding domain, flanking the S2′ cleavage site via its mannose-binding properties. This interaction sterically impedes proteolytic activation of the spike, a molecular step essential for membrane fusion. ConA exhibited nanomolar efficacy against hCoV-NL63 infections in vitro and significantly reduced viral load and mitigated lung pathology in hCoV-NL63-infected mice in vivo . Our findings reveal specific N-linked glycosylation sites as a major vulnerability of the spike and highlight ConA as a prototype for the development of lectin-based therapeutics against emerging coronavirus infections. IMPORTANCE The rapid evolution of SARS-CoV-2 variants, which evade current vaccines and therapeutics by altering epitopes on the spike protein, highlights a critical need for broad-spectrum antivirals. This study investigates concanavalin A (ConA), a legume lectin that targets highly conserved N-linked glycosylation sites on the spike protein, as a potential pan-coronavirus entry inhibitor. ConA broadly inhibits diverse coronaviruses by blocking spike-mediated membrane fusion. In contrast to previously reported antiviral lectins, ConA binds specifically to high-mannose oligosaccharides by targeting two phylogenetically conserved residues in the S2 subunit outside the receptor-binding domain. Consequently, ConA binding prevents the proteolytic activation of S2′ and effectively inhibits membrane fusion and coronavirus infection both in vitro and in vivo . This work identifies conserved N-glycosylation sites on the spike protein as stable, vulnerable targets for antiviral intervention, distinct from the variable epitopes recognized by antibodies. These findings indicate that lectins like ConA may provide a promising approach for developing effective antivirals against emerging coronaviruses.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Traditional Chinese Medicine Syndrome, Guangzhou University of Chinese Medicine, Guangzhou, China.
- Department of Basic Research, Guangzhou International Bio-Island, Guangzhou National Laboratory, Guangzhou, China.
- State Key Laboratory of Respiratory Disease, Guangzhou Medical University, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou National Laboratory Clinical Base, School of Basic Medical Sciences, Gu…
- Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, China.
- University of the Chinese Academy of Sciences, Beijing, China.
ORCID-Profile: Shi Yu, Xiancai Ma, Geng Li, Shaobo Wang
Zitieren
APA
Guo, D., Yu, S., Ma, K., Tao, H., Wang, Q., Han, S., Ai, Q., Hu, H., Ma, X., Li, G., & Wang, S. (2026). Concanavalin A targets phylogenetically conserved N-linked glycans on coronavirus spike proteins for broad-spectrum antiviral activity. Journal of Virology, 100(5). https://doi.org/10.1128/jvi.01679-25
Vancouver
Guo D, Yu S, Ma K, Tao H, Wang Q, Han S, et al. Concanavalin A targets phylogenetically conserved N-linked glycans on coronavirus spike proteins for broad-spectrum antiviral activity. Journal of Virology. 2026;100(5). doi:10.1128/jvi.01679-25
BibTeX
@article{Guo2026,
author = {Guo, Dekuan and Yu, Shi and Ma, Kaixiong and Tao, Hua and Wang, Qingxing and Han, Sirui and Ai, Qiangyun and Hu, Huina and Ma, Xiancai and Li, Geng and Wang, Shaobo},
title = {Concanavalin A targets phylogenetically conserved N-linked glycans on coronavirus spike proteins for broad-spectrum antiviral activity},
journal = {Journal of Virology},
year = {2026},
volume = {100},
number = {5},
doi = {10.1128/jvi.01679-25}
}
EUVIMED